Comparison of in Vivo, in Vitro 3T MR Spectroscopy and Proton NMR Spectroscopy for the Fluid from Cystic Tumor: Preliminary Study.
- Author:
Hui Joong LEE
1
;
Jong Yeol KIM
;
Yongmin CHANG
Author Information
1. Department of Radiology, Kyungpook National University, School of Medicine, Korea. knuhrad@yahoo.co.kr
- Publication Type:In Vitro ; Original Article
- Keywords:
Magnetic resonance (MR);
Spectroscopy;
Cystic tumor;
Nuclear magnetic resonance
- MeSH:
Magnetic Resonance Spectroscopy;
Mucins;
Pancreas;
Protons;
Sensitivity and Specificity;
Spectrum Analysis
- From:Journal of the Korean Society of Magnetic Resonance in Medicine
2008;12(2):107-114
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The aim of this study is to determine possibility of application of in vivo proton (1H) magnetic resonance spectroscopy (MRS) in distinguishing cystic mass arising around pancreas by comparison of in vivo MRS, in vitro MRS using 3T MR machine, based on nuclear magnetic resonance (NMR). MATERIALS AND METHODS: We obtained spectra of in vivo MRS, in vitro MRS and NMR from abdominal mass arising around pancreas (mucinous cystic neoplasm=5, intraductal papillary mucin producing tumor=5, pseudocyst=1, and lymphangioma=1). We estimated existence of peak of in vivo MRS, and in vitro MRS concordant to that of NMR. We also evaluated differential peak for predicting specific disease. RESULTS: Correlation of presence of peak with NMR showed showed sensitivity of 29.6%, specificity of 82.6% and accuracy of 67.7% on in vivo MRS (p = 0.096, McNemar test), sensitivity of 57.1% and specificity of 92.6% and accuracy of 82.3% on in vitro MRS (p = 0.362, McNemar test). The spectra of NMR for IPMT showed more frequent peaks at 3.5-4.0 ppm (p=0.026). CONCLUSION: Although chemical analysis, using NMR could be regarded as possible tool to differentiate cystic masses, in vivo and in vitro MRS need further technical evolution for clinical application.
